Our bladder is an organ we tend not to think about until it gives us trouble. Like other organ, it helps keep the whole body ...

As the researchers behind Pfizer and Astellas' Padcev and Merck's Keytruda have taken victory laps on the heels of the ...

(TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has approved PADCEV (R) (enfortumab vedotin-ejfv), a Nectin-4 directed ...

The FDA has approved Pfizer and Astellas’ Padcev (enfortumab vedotin-ejfv) plus Merck’s Keytruda (pembrolizumab) as a perioperative treatment for adults with muscle-invasive bladder cancer who are ...

This week, Pay.com.au, Ruminant Biotech, Australis Scientific and Paperly collectively raised more than $50 million in new ...

Appoints Accomplished Life Sciences Executive Christina Rossi to its Board of Directors -IRVINE, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) -- CG ...

The Pro Football Hall of Famer said he was in "straight dad mode" watching son Shedeur lead the Cleveland Browns to a win in ...

Detailed price information for Theralase Technologies Inc (TLT-X) from The Globe and Mail including charting and trades.

There are numerous reasons why the Colorado football team is limping to Saturday’s finish line and a trip to Kansas State for ...

Not every transfer portal class is going to click, and coach Deion Sanders learned that lesson this season as several newcomers struggled to make an i ...

Two late-breaking podium presentations and three posters continue to demonstrate cretostimogene as a potential backbone therapy for a broad range of NMIBC patients. IRVINE, Calif.

Imfinzi is the first immunotherapy approved for perioperative use to treat gastric and gastroesophageal junction cancers.